Permanent improvement of thyroid-related upper eyelid retraction from bethanidine.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D003315:Cornea / Q000187:drug effects; D005128:Eye Diseases / Q000188:drug therapy* / Q000209:etiology; D005143:Eyelids; D005500:Follow-Up Studies; D006145:Guanethidine / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications / Q000601:surgery; D011680:Pupil / Q000187:drug effects; D013965:Thyroidectomy
D000959:Antihypertensive Agents; D006146:Guanidines; D006145:Guanethidine